BioRestorative Therapies, Inc. Price Today
BioRestorative Therapies, Inc.
BRTX
Healthcare
$11.27M
💰
Market Cap
0
💸
Price to Earnings
$-4.8
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
5 |
Strong Buy |
2 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
BRTX Price Forecast Target
2.8 👉 15.0 +430%
BRTX EPS Forecast
-4.8 👉 -3.3 +-31%
Financials
Profit Margin
0 %
Revenue Growth
95.6 %
Dividend
$ 0
Held Percent
18.9% - Insiders
16.8% - Institutions
64.3% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $428,250.0
-
💰 Wealth Alliance $195,433.0
-
💰 Two Sigma Advisers, LP $98,940.0
-
💰 Mariner, LLC $90,671.0
-
💰 State Street Corporation $69,560.0
Stock Ideas
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…📮FAQ
Some Frequently Asked Questions.
The BioRestorative Therapies, Inc. industry is Biotechnology
The BioRestorative Therapies, Inc. sector is Healthcare
The BioRestorative Therapies, Inc. forecasted predicted Price to Earnings PE ratio is -0.8
The BioRestorative Therapies, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of BioRestorative Therapies, Inc. is $11.27M
There are total of 2907703 float shares with 16.8% held by Institutions and 18.9% held by insiders
The MBioRestorative Therapies, Inc. forecasted Earnings per Share EPS is $-3.3
The BioRestorative Therapies, Inc. Earnings per Share EPS is -4.8
The BioRestorative Therapies, Inc. company has $119800 gross profits with 0 profit margins
The BioRestorative Therapies, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The BioRestorative Therapies, Inc. Revenue is $135100 with 0.956 revenue growth
The price target for BioRestorative Therapies, Inc. stock is $15.0 for the high target and $10.0 for the low target
The consensus analyst recommendations for BioRestorative Therapies, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for BioRestorative Therapies, Inc. is Buy, with the following breakdown:
- Buy: 5
- Strong Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of BioRestorative Therapies, Inc. is 60.2
The dividend of BioRestorative Therapies, Inc. is $0
The dividend yield of BioRestorative Therapies, Inc. is 0%
The biggest institutional and mutual fund holders of BioRestorative Therapies, Inc. stock are
- Vanguard Group Inc
- Wealth Alliance
- Two Sigma Advisers, LP
- Mariner, LLC
The BioRestorative Therapies, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0